The Valley Desk

NCT02296138 · Interventional trial

Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.

Overall registry status Completed

Phase 3

Conditions Pulmonary Disease, Chronic Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov